Name of partner: Evotec , Toulouse, France.
Name of leader: Nathalie Alet
Objectives: to identify metabolic genes that are modulated or mutated in acute myeloid leukemia patient samples. Set up in vivo model(s) suitable for validation of their interest.
Expected Results: We will model a metabolic gene profile in acute myeloid leukemia and link this gene profile to patient outcome according to the treatment received. Then drugs/compounds potentially modulating the metabolic profile in a beneficial way may be tested in vivo.
As part of our MSCA-ESR training on complementary skills we got to leave the wet lab to explore what happens on the other side of the bench and to learn what it means to be a scientific editor. This is our story.
The new work developed in the lab of META-CAN’s coordinator, Cristina Muñoz-Pinedo, has finally seen the light in a paper at PNAS. The study has been possible thanks to an amazing group of researchers and the funding of two MSCA Actions: TRAINERS (GA 675448) and META-CAN (GA 766214).
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 766214.
Bellvitge Biomedical
Research Institute (IDIBELL)
Hospital Duran i Reynals, 3a planta
Gran Via de l’Hospitalet, 199
08908 L’Hospitalet del Llobregat
Barcelona, Spain
